FEDERICO, Massimo
 Distribuzione geografica
Continente #
EU - Europa 18.539
NA - Nord America 18.182
AS - Asia 7.840
SA - Sud America 543
AF - Africa 432
OC - Oceania 350
Continente sconosciuto - Info sul continente non disponibili 19
Totale 45.905
Nazione #
US - Stati Uniti d'America 17.402
FR - Francia 10.743
CN - Cina 4.632
IT - Italia 2.885
DE - Germania 1.309
JP - Giappone 1.201
GB - Regno Unito 942
CA - Canada 631
IN - India 418
ES - Italia 383
AU - Australia 317
NL - Olanda 286
SE - Svezia 269
VN - Vietnam 256
RU - Federazione Russa 250
IE - Irlanda 248
KR - Corea 215
BR - Brasile 199
TR - Turchia 185
HK - Hong Kong 175
CZ - Repubblica Ceca 160
ZA - Sudafrica 138
UA - Ucraina 122
CH - Svizzera 119
MX - Messico 115
AR - Argentina 100
FI - Finlandia 98
TW - Taiwan 97
CL - Cile 83
SG - Singapore 83
PT - Portogallo 77
BE - Belgio 74
ID - Indonesia 74
TH - Thailandia 72
LY - Libia 70
GR - Grecia 68
IL - Israele 68
CO - Colombia 66
RO - Romania 66
HU - Ungheria 65
PL - Polonia 65
DK - Danimarca 60
PE - Perù 58
AE - Emirati Arabi Uniti 56
PH - Filippine 53
AT - Austria 48
EG - Egitto 48
SA - Arabia Saudita 44
PK - Pakistan 41
NO - Norvegia 38
MY - Malesia 36
TN - Tunisia 36
IR - Iran 33
NZ - Nuova Zelanda 33
BG - Bulgaria 28
LT - Lituania 26
HR - Croazia 24
NG - Nigeria 21
DZ - Algeria 18
IQ - Iraq 18
LB - Libano 17
MA - Marocco 17
UY - Uruguay 17
JO - Giordania 16
EU - Europa 12
MK - Macedonia 12
SI - Slovenia 12
SK - Slovacchia (Repubblica Slovacca) 12
KE - Kenya 10
EC - Ecuador 9
MD - Moldavia 9
RS - Serbia 9
BD - Bangladesh 8
CR - Costa Rica 8
ET - Etiopia 8
PA - Panama 8
SN - Senegal 8
TZ - Tanzania 8
CI - Costa d'Avorio 7
AL - Albania 6
AM - Armenia 6
MO - Macao, regione amministrativa speciale della Cina 6
GN - Guinea 5
GT - Guatemala 5
LV - Lettonia 5
NE - Niger 5
SC - Seychelles 5
AP - ???statistics.table.value.countryCode.AP??? 4
BO - Bolivia 4
BY - Bielorussia 4
EE - Estonia 4
IS - Islanda 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LU - Lussemburgo 4
PR - Porto Rico 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
UZ - Uzbekistan 4
BT - Bhutan 3
Totale 45.846
Città #
Fairfield 2.298
Chongqing 2.270
Houston 1.380
Woodbridge 1.275
Ashburn 1.254
Seattle 987
Santa Cruz 769
Cambridge 764
Buffalo 729
Beijing 679
Ann Arbor 662
Wilmington 594
Des Moines 348
Tokyo 317
Munich 280
Modena 265
San Diego 260
Mountain View 230
Milan 221
Dong Ket 210
Stockholm 206
Shanghai 191
Paris 183
Rome 183
Silver Spring 175
Ottawa 158
Dublin 147
Wuhan 139
Chicago 135
Boardman 130
Las Vegas 130
Los Angeles 120
Clearwater 114
Nanjing 113
Phoenix 113
New York 108
Muizenberg 106
Toronto 97
London 86
Southend 86
Tianjin 85
Duncan 81
Guangzhou 80
Hangzhou 73
Helsinki 73
Menlo Park 68
Saint Petersburg 67
Barcelona 64
Shenyang 64
San Francisco 63
Bengaluru 62
University Park 62
Taipei 59
Riva 57
Central District 55
Boston 54
Central 50
Buenos Aires 49
Istanbul 49
Seoul 49
Changsha 48
Dallas 48
Madrid 48
Bologna 46
Lima 46
Henderson 44
Rochester 44
Singapore 43
Turin 43
Florence 41
Nürnberg 41
Jinan 37
Sydney 37
Amsterdam 35
Padova 35
Santiago 35
Hanoi 34
Redmond 34
Baltimore 33
Brisbane 33
Budapest 33
Chengdu 33
Moscow 33
Enfield 32
Melbourne 32
Philadelphia 32
Naples 31
Atherstone 30
Jakarta 30
San Mateo 30
Ankara 29
Atlanta 29
Bogotá 29
Bremen 29
San Jose 29
Upper Marlboro 29
Zhengzhou 29
Bangkok 28
Leawood 28
Montreal 28
Totale 21.184
Nome #
Transformed follicular lymphoma, file e31e124d-2acf-987f-e053-3705fe0a095a 3.539
Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 1: PTCL-NOS, FTCL, AITL, ALCL, file e31e124d-78e9-987f-e053-3705fe0a095a 2.790
Follicular lymphoma international prognostic index., file e31e124c-38ff-987f-e053-3705fe0a095a 1.543
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12, file e31e124b-3355-987f-e053-3705fe0a095a 1.525
Malattia celiaca e linfoma, file e31e124c-4abd-987f-e053-3705fe0a095a 1.043
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 Trial, file e31e124b-362a-987f-e053-3705fe0a095a 747
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lmphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi, file e31e124b-35f7-987f-e053-3705fe0a095a 745
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk, file e31e124c-44b6-987f-e053-3705fe0a095a 729
Hairy cell leukemia: a reversible disease? A report of two cases of spontaneous remission, file e31e124c-5fe4-987f-e053-3705fe0a095a 684
Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters., file e31e124b-e814-987f-e053-3705fe0a095a 673
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project, file e31e124b-2342-987f-e053-3705fe0a095a 658
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience, file e31e124c-1ddb-987f-e053-3705fe0a095a 636
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma, file e31e124d-248f-987f-e053-3705fe0a095a 609
Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form, file e31e124c-5e65-987f-e053-3705fe0a095a 576
PRIMARY GASTROINTESTINAL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 58 CASES, file e31e124c-610f-987f-e053-3705fe0a095a 562
Daily variation of immunoreactive serum interleukin-6 levels in multiple myeloma, file e31e124c-4922-987f-e053-3705fe0a095a 559
Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin, file e31e124c-5b2e-987f-e053-3705fe0a095a 551
Splenic marginal zone lymphoma: a prognostic model for clinical use., file e31e124c-28b2-987f-e053-3705fe0a095a 536
Patogenesi complessa di una emopatia sistemica: la tricoleucemia, file e31e124c-62f4-987f-e053-3705fe0a095a 536
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-cell Lymphoma Project, file e31e124b-25d9-987f-e053-3705fe0a095a 530
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations, file e31e124c-3c5a-987f-e053-3705fe0a095a 525
STIFF-MAN SYNDROME IN A PATIENT WITH HODGKINS-DISEASE - AN UNUSUAL PARANEOPLASTIC SYNDROME, file e31e124c-8860-987f-e053-3705fe0a095a 525
Cancer incidence in eastern Libya: The first report from the Benghazi Cancer Registry, 2003, file e31e124c-21ef-987f-e053-3705fe0a095a 524
Incidence of AIDS-Defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998, file e31e124c-46ba-987f-e053-3705fe0a095a 520
T-cell lymphomas: where we are and where we a re moving forward, file e31e124b-ae23-987f-e053-3705fe0a095a 515
Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma, file e31e124d-7944-987f-e053-3705fe0a095a 506
Usefulness of breast MRI in a patient with genetic risk, file e31e124c-4443-987f-e053-3705fe0a095a 487
Hairy Cell Leukemia. A therapeutical update, file e31e124c-7eb0-987f-e053-3705fe0a095a 483
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta, file e31e124c-5e6b-987f-e053-3705fe0a095a 482
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study, file e31e124c-38d9-987f-e053-3705fe0a095a 478
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study, file e31e124b-2e13-987f-e053-3705fe0a095a 473
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades, file e31e124c-787c-987f-e053-3705fe0a095a 468
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial, file e31e124f-7d67-987f-e053-3705fe0a095a 462
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL, file e31e124c-57f6-987f-e053-3705fe0a095a 458
Hereditary risk of breast cancer: not only brca, file e31e124c-39af-987f-e053-3705fe0a095a 409
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe, file e31e124c-45df-987f-e053-3705fe0a095a 381
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias., file e31e124c-142a-987f-e053-3705fe0a095a 361
Induction chemotherapy stategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients., file e31e124c-42a6-987f-e053-3705fe0a095a 357
Estimated and observed cancer incidence in Italy: a validation study, file e31e124c-2406-987f-e053-3705fe0a095a 352
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: a large multicenter study involving 1191 patients, in the pre and post rituximab era, file e31e124b-2d72-987f-e053-3705fe0a095a 343
Cancer profile in Eastern Libya: incidence and mortality in the year 2004., file e31e124c-0fc1-987f-e053-3705fe0a095a 317
Estimates of cancer burden in Italy, file e31e124b-e645-987f-e053-3705fe0a095a 316
Reevaluation of prognostic significance of symptoms in Hodgkin's disease, file e31e124c-62ee-987f-e053-3705fe0a095a 316
Interim PET-CT scan in advanced Hodgkin's lymphoma, file e31e124b-d986-987f-e053-3705fe0a095a 310
Epidemiological overview of Hodgkin lymphoma across the Mediterranean Basin, file e31e124b-b2fa-987f-e053-3705fe0a095a 297
Serum albumin in Hodgkin's disease, file e31e124c-62ea-987f-e053-3705fe0a095a 291
Multicenter comparative multimodality surveillance of women at genetic-familial risk for breast cancer (HIBCRIT study): interim results., file e31e124c-1d00-987f-e053-3705fe0a095a 276
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemia, file e31e124b-2b17-987f-e053-3705fe0a095a 271
Pattern of cancer risk in person with AIDS in Italy inthe HAART era, file e31e124c-191d-987f-e053-3705fe0a095a 253
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma - A multicenter study of the Intergruppo Italiano Linfomi showing prolonged disease free survival in patients, file e31e124c-3a2a-987f-e053-3705fe0a095a 251
Prognosis of screen-detected breast cancers: results of a population based study, file e31e124c-2706-987f-e053-3705fe0a095a 246
IMPACT Working Group: effectiveness of service screening: a case-control study to assess breast cancer mortalità reduction., file e31e124c-239c-987f-e053-3705fe0a095a 243
Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma, file e31e124e-572e-987f-e053-3705fe0a095a 241
ESMO guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL), file e31e124b-2a31-987f-e053-3705fe0a095a 238
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017), file e31e124c-b85f-987f-e053-3705fe0a095a 238
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial, file e31e124b-ecdf-987f-e053-3705fe0a095a 233
Breast Carcinoma Survival in Europe and the United States: A Population-Based Study, file e31e124c-42d9-987f-e053-3705fe0a095a 231
Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size, file e31e124c-38c5-987f-e053-3705fe0a095a 230
Total body computed tomography scan in the initial work-up of binet stage a chronic lymphocytic leukemia patients: results of the prospective, multicenter o-cll1-gisl study, file e31e124b-2e10-987f-e053-3705fe0a095a 228
Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients, file e31e124b-b230-987f-e053-3705fe0a095a 227
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years., file e31e124b-2ed2-987f-e053-3705fe0a095a 225
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monodenopathic variety, file e31e124c-5e67-987f-e053-3705fe0a095a 224
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi, file e31e124b-2fa6-987f-e053-3705fe0a095a 223
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients, file e31e124b-fb99-987f-e053-3705fe0a095a 222
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study, file e31e124b-f0fd-987f-e053-3705fe0a095a 216
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL), file e31e124b-29b3-987f-e053-3705fe0a095a 213
Estimates of cancer burden in Emilia-Romagna, file e31e124b-eb18-987f-e053-3705fe0a095a 213
The outcome of peripheral t-cell lymphoma patients failing first-line therapy: A report from the prospective, international t-cell project, file e31e124d-73b4-987f-e053-3705fe0a095a 212
Splenosis peritonei., file e31e124c-3951-987f-e053-3705fe0a095a 210
Reply to T.P. Vassilakopoulos et al, file e31e124b-d07d-987f-e053-3705fe0a095a 209
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia., file e31e124b-22d6-987f-e053-3705fe0a095a 207
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study, file e31e124c-1499-987f-e053-3705fe0a095a 205
ABVD versus Stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial, file e31e124c-4e4f-987f-e053-3705fe0a095a 203
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi, file e31e124b-d98f-987f-e053-3705fe0a095a 200
A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma, file e31e124b-3166-987f-e053-3705fe0a095a 196
Do We Need Maintenance with Anti-CD20 Antibody after First-Line Therapy for All Newly Diagnosed Follicular Lymphoma Patients?, file e31e124e-848f-987f-e053-3705fe0a095a 194
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials, file e31e124d-2039-987f-e053-3705fe0a095a 193
Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis, file e31e124b-22d8-987f-e053-3705fe0a095a 191
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network, file e31e124d-7125-987f-e053-3705fe0a095a 191
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma - The experience of the gruppo italiano studio linfomi, file e31e124c-38c8-987f-e053-3705fe0a095a 190
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia., file e31e124b-2e82-987f-e053-3705fe0a095a 188
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL), file e31e124c-38be-987f-e053-3705fe0a095a 188
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma, file e31e124c-42df-987f-e053-3705fe0a095a 188
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study, file e31e1250-848f-987f-e053-3705fe0a095a 188
Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas., file e31e124c-49ce-987f-e053-3705fe0a095a 186
High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results., file e31e124c-115e-987f-e053-3705fe0a095a 185
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors, file e31e124c-24b4-987f-e053-3705fe0a095a 183
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma, file e31e124c-20c3-987f-e053-3705fe0a095a 180
Ovarian cancer: can proteomics give new insights for therapy and diagnosis?, file e31e124b-2c28-987f-e053-3705fe0a095a 178
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study., file e31e124c-1495-987f-e053-3705fe0a095a 177
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma, file e31e124c-16e4-987f-e053-3705fe0a095a 175
Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma, file e31e124b-a985-987f-e053-3705fe0a095a 173
Case studies of elderly patients with non-Hodgkin's lymphoma., file e31e124b-1b18-987f-e053-3705fe0a095a 170
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene, file e31e124c-4bb7-987f-e053-3705fe0a095a 170
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study, file e31e124b-b234-987f-e053-3705fe0a095a 169
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes., file e31e124c-3903-987f-e053-3705fe0a095a 168
Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997-2001), file e31e124c-39e8-987f-e053-3705fe0a095a 166
Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma., file e31e124b-2138-987f-e053-3705fe0a095a 162
Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply, file e31e124e-9791-987f-e053-3705fe0a095a 162
Prognostic value of morphology and hormone receptor status in breast cancer - a population based study, file e31e124c-42db-987f-e053-3705fe0a095a 161
Totale 41.787
Categoria #
all - tutte 86.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.377 0 0 0 0 0 0 0 0 0 355 549 473
2019/20205.829 442 328 349 471 476 728 700 588 599 403 412 333
2020/20218.097 615 635 617 664 792 854 573 673 629 668 709 668
2021/20228.040 787 721 842 943 734 315 568 482 411 407 1.273 557
2022/20235.883 317 410 900 656 424 786 432 373 420 412 486 267
2023/202414.826 294 276 265 362 342 325 1.712 9.475 1.508 267 0 0
Totale 47.068